Denmark wanted advice on handling Trump. It turned to Ozempicโ€™s boss.

Lars Fruergaard Jรธrgensen might not be a household name, but his companyโ€™s drug Ozempic is. And its success has thrust him โ€” reluctantly โ€” into the limelight.

Europe must confront soaring chronic disease rates, warns WHO

From infancy to old age, people in the region are facing health crises.

Time to follow the science: How Europe can unlock a new era of diabetes care [Promoted content]

We are living an exciting but also daunting time for diabetes care. While a genuine epidemic of diabetes is spreading across Europe and the world, new tools and treatments are emerging to manage this condition. The fact is however that…
The post Time…

A massive diabetes challenge and pharma-tech moonshots, Europe starts 2025 in launch mode

Diabetes drugs now represent over 75% of total sales in the metabolic disorders market, up from below 40% ten years ago. The race is on to heal an ageing population.
The post A massive diabetes challenge and pharma-tech moonshots, Europe starts 2025 in…

Why Europeโ€™s health policies must prioritize chronic kidney disease

Undetected Chronic Kidney Disease affects millions in Europe, but it could be preventable, manageable and tackled with the right policies.

Guns, lies and audiotape: How Bidenโ€™s family ties could lead to another pardon

For decades, a scandal-plagued Mississippi family has cozied up to the president. How will the relationship end?

115,000 Belgians join new diabetes care pathway, but prevention remains a critical challenge

One euro invested in diabetes prevention can save eight euros in the future. Diabetes is crushing Europe’s health budgets, but Belgium is trying to get ahead of the curve.

Diabetes dynamics are accelerating, Europeโ€™s weak diabetes strategy is causing longterm economic pain [Advocacy Lab Content]

This special report looks at the urgent decisions facing Europe’s policymakers as diabetes dynamics accelerate, and chronic underfunding of diabetes management leads to even higher long-term financial and economic pain.

Is a balanced diet the key to managing diabetes? [Promoted content]

Diabetes is a major public health challenge, affecting millions worldwide. On World Diabetes Day, we highlight the importance of a healthy lifestyleโ€”particularly good nutritionโ€”in managing diabetes, improving glycaemic control, and reducing complicatio…

EU health systems struggling to address diabetes crisis, reveals new analysis [Advocacy Lab Content]

As diabetes cases surge across Europe, healthcare systems are grappling with an escalation, leaving millions without sufficient access to early diagnosis, preventive care, and innovative treatments.

Diabetes inequity risks damaging Europeโ€™s fragile health systems [Advocacy Lab Content]

Insulin affordability and availability across Europe are just part of the complex diabetes management dynamics challenging the EUโ€™s fragile and diverse healthcare systems. Socioeconomic and regional disparities play their part, but so too does innovati…

The future EU commissionersโ€™ promises: Everything you need to know

We pored over more than 400 pages of written answers so you donโ€™t have to.

Unemployed people could be given weight-loss drugs to return to work in UK

A study will assess changes in employment status and sick days when people take the drug.

World leaders tout AMR declaration, while NGOs sigh

SNEAK PEEK โ€” Leaders have agreed to a political declaration on antimicrobial resistance. NGOs are disappointed, but is it really so bad? โ€” The World Health Organization has allied with TikTok to curb the spread of health misinformation. โ€” What will it take to be prepared for the next pandemic? Itโ€™s not looking good, Gastein [โ€ฆ]

Health and productivity losses from obesity โ€˜far outstrip weight-loss jab costsโ€™

Exclusive: ยฃ100bn-a-year cost of obesity to UK makes clear economic case for use of drugs such as Ozempic, says reportSpiralling healthcare costs and productivity losses from the global obesity crisis far outstrip the cost of new weight-loss drugs, acc…

Type 1 Diabetes can be fast, but we can be faster! A call to boost early detection [Promoted content]

The European Diabetes Forum (EUDF), the International Diabetes Federation (IDF) Europe, the Spanish Diabetes Federation (FEDE), the Parliamentarians for Diabetes Global Network (PDGN) and Sanofi co-organised the Early Detection Policy Forum to accelera…

Trudeau digs in as his party ponders his ability to win

Whatever the prime minister is selling after almost nine years in power, Canadians are no longer buying.

Itโ€™s time to address this leading cause of death: COPD

A new report about the global state of COPD offers insights from 30 national experts on how policy action can be implemented worldwide.

From a hospital in Gaza: โ€˜Please let me dieโ€™

We urge the international and medical community to demand an immediate and permanent cease-fire, and to allow access to the humanitarian aid so desperately needed.

Europeโ€™s diabetes tsunami, a crisis in full view [Advocacy Lab Content]

Europe is spending more on diabetes in a year, than on the war in Ukraine. The diabetes tsunami is a public health crisis which threatens to overwhelm healthcare systems and economic progress.

Paris court rejects Agent Orange appeal against Bayer-Monsanto

Tran To Nga says she has had tuberculosis, cancer and type II diabetes after being exposed to the herbicide in 1966.

9 times politicians reached for Ozempic โ€” or more trad diets

From Ozempic to “bulletproof” coffee, politicians are just like the rest of us when it comes to seeking a shortcut to slim.

9 times politicians reached for Ozempic โ€” or more trad diets

From Ozempic to “bulletproof” coffee, politicians are just like the rest of us when it comes to seeking a shortcut to slim.

Novo Nordisk confirms huge increase in sales despite supply constraints

Novo Nordisk is on track to make a significant contribution to Denmark’s GDP through its obesity and diabetes treatments, despite supply constraints, according to the company’s financial report for the first half of 2024.

Novo Nordisk cuts profit outlook after weaker sales of weight-loss drug Wegovy

Danish company, which also makes Ozempic, faces increasing competition from US rival Eli LillyNovo Nordisk has cut its annual profit expectations after posting weaker-than-expected sales of its weight-loss drug Wegovy, fuelling investor concerns over g…

Severe heat causes more than 175,000 deaths annually across European region

Europe keeps warming at about twice the global average.

Ozempic-maker blasts Biden in price row

Novo Nordisk has denied U.S. president’s claim it is “ripping off” consumers, saying the reality isn’t so simple.

Europe eating itself poorer with rising diabetes costs, data, health-tech could reverse trend [Advocacy Lab Content]

Diabetes is draining cash from public and private sector budgets. Itโ€™s time for Europe to curb its sugar high, get fiscally fit and economically strong โ€“ the EU needs a French Fries Revolution.

Ozempic maker Novo Nordisk invests $4bn to expand US production

Pharma group plans plant in North Carolina to produce diabetes drug and weight-loss product WegovyBusiness live โ€“ latest updatesNovo Nordisk is to invest more than $4bn (ยฃ3.2bn) in US manufacturing as it battles to keep up with booming demand for its o…

Diabetes and cardiovascular disease causing profound clinical, psychosocial, socioeconomic impacts [Advocacy Lab Content]

Cardiovascular disease related to diabetes is wrecking Europeโ€™s public health budgets at an astonishing rate. Patients with diabetes are three times more likely to develop CVD, while one in three will experience some form of vision loss.

Europas Rechte hรคlt Trump die Treue

Das Briefing dazu, wie sich Entscheidungen in Brรผssel auf Sie auswirken. Mit dem Wissen des grรถรŸten Newsrooms der europรคischen Hauptstadt. Im Browser anzeigen oder hier anhรถren von JรœRGEN KLร–CKNER Mit LAURA HรœLSEMANN und JULIUS BRINKMANN DIE TOP-THEMEN โ€” NATO-Treffen endet: Stoltenberg hat die Mitgliedslรคnder des Verteidigungsbรผndnisses dazu aufgerufen, sich auf jรคhrliche Militรคrhilfen fรผr die Ukraine [โ€ฆ]

US Democrats in full-blown โ€˜freakoutโ€™ over Biden

One adviser to major Democratic donors keeps a running list of reasons Biden could lose.

The US food industry has long buried the truth about their products. Is that coming to an end?

The FDA is developing front-of-package labels that corporations may have to start printing as early as 2027Ultra-processed foods are ultra bad for you. Hereโ€™s what to knowStep into a grocery store in France and youโ€™re liable to see a green, yellow or r…

Medicine shortages in England โ€˜beyond criticalโ€™, pharmacists warn

Survey has revealed challenges faced by pharmacists and risk of harm to patients as key drugs are unavailableโ€˜Weโ€™re firefighting in the backgroundโ€™: the pharmacists coping with record drug shortagesDrug shortages in England are now at such critical lev…

US presidential candidate claims doctor told him a worm ate part of his brain

The claim comes from a 2012 deposition during divorce proceedings.

Severe asthma: A call for global policy action

People living with severe asthma have been overlooked and underserved for too long. Timely, equitable and high-quality care for this condition needs to be an integral part of every health system.

Danish firm behind weight-loss drug Wegovy raises profit forecast to ยฃ15.3bn

Novo Nordisk, which is now Europeโ€™s most valuable company, also reports strong sales of diabetes drug Ozempic Strong sales of diabetes and weight loss drugs Ozempic and Wegovy have prompted the Danish pharmaceutical company Novo Nordisk to raise its 20…

Europeโ€™s amputation crisis, diabetes experts call for urgent new screening programs [Advocacy Lab Content]

Europeans suffer 100,000 amputations a year because of the escalating issue of โ€˜diabetic footโ€™. Diabetes already burdens health systems, but without more frequent monitoring programmes, experts warn the amputation crisis will get worse.

Unlocking the full value of adult immunization

It is time to adopt a prevention-first mindset.

โ€˜Itโ€™s eating what the sea providesโ€™: Galiciaโ€™s Atlantic diet eclipses Mediterranean cousin

In Fisterra in north-west Spain, a diet rich in seafood, fruit and vegetables survives, and has been found to reduce the risk of type 2 diabetes and heart-related conditionsSeagulls shriek, boats bob and the morning sun silvers the waters off the Coast…

Weight loss drugs like Ozempic not linked with suicidal thoughts, EU drugs regulator finds

There is no evidence to suggest a link between the use of weight loss drugs like Ozempic and suicidal thoughts, the EUโ€™s drugs regulator has found. The European Medicines Agency (EMA)โ€™s drug safety committee, PRAC, evaluated the risk of possible side effects in people who have used a class of drugs known as GLP-1, after [โ€ฆ]

Future of health: Time for Europe to connect the dots

Innovation can deliver patient-centric, digitally advanced, resilient and sustainable health care โ€” a new video series shows whatโ€™s possible if the EU seizes this opportunity for transformation.

Diabetes patients need election manifesto pledge from all EU parties, says EUDF [Advocacy Lab Content]

The EPP is still the only party to directly address diabetes in its 2024 election manifesto. The European Diabetes Forum is now asking all of Europeโ€™s politicians to pledge their manifesto support to fight diabetes in Europe.

Urgent call to policymakers โ€“ make chronic kidney disease a public health priority

Governments and policymakers must act now to elevate chronic kidney disease (CKD) as an urgent health policy priority, to bring the best possible outcomes for patients, caregivers, health systems, the economy and our planet.

Europeโ€™s champion sitters: Even the sporty Dutch are falling victim to โ€˜chair-use disorderโ€™

Long hours spent at desks and sofas leads to 21,000 deaths a year in the Netherlands from cardiovascular disease, diabetes and cancerThe Dutch are perceived as a nation of healthy giants, leaping on their bikes to cycle energetically across flat lands….

Theresa May: The Brexit prime minister who should have been great

Westminster says farewell to Britainโ€™s second female premier brought down by her partyโ€™s civil war over Europe.

Ukraineโ€™s health system is a symbol of resilience

“I marvel at the resilience of Ukraineโ€™s health system, battered by war and yet still standing.”

Return of (some) masks! Belgium advises face coverings amid flu surge

Authorities stressed the measure, which is recommended for vulnerable people, will be lifted “as soon as possible.”

POLITICO 2024-02-05 04:00:00

References 1Institute for Health Metrics and Evaluation (2019), Global Burden of Disease (GBD) study. Available at: http://ghdx.healthdata.org/gbd-results-tool. Accessed 12 September 2023. 2Fred Kleinsinger (2020), โ€œThe Unmet Challenge of Medication Nonadherenceโ€, The Permanent Journal 22. DOI: 10.7812/TPP/18-033. Accessed 12 September 2023. 3Institut Sapiens (2023), Amรฉliorer lโ€™adhรฉsion thรฉrapeutique: un enjeu de santรฉ publique. Available at: https://www.institutsapiens.fr/wp-content/uploads/2023/06/Ameliorer-ladhesion-therapeutique-V1.pdf Accessed [โ€ฆ]

PMQs scorecard: Starmer hits Sunak over Tory โ€˜shitshowโ€™

The Labour leader opted to focus on the whisperings of discontent in the Conservatives

NHS medicines shortage putting lives at risk, pharmacists warn

Unpublished figures reveal a doubling of products in short supply over past two yearsโ€˜The worst Iโ€™ve known itโ€™: the struggle to get vital medicinesAnalysis: why is UK being hit by medicine supply shortages?An unprecedented medicines shortage in the NHS…

Diabetes care in Europe: The path forward

There are millions of people in Europe who are affected by diabetes and related conditions. This number is only expected to grow in the coming years. However, with technological advancements, it is possibleย that those affected by the disease are able…

Deaths from toxic air on the rise as EU battles to tackle pollution

EU capitals are struggling to respect Europe’s air quality standards and are pushing back against setting stricter rules.

The future for Europe and the role of medical innovation

Why medical research is essential for reducing the burden of disease, the burden on health care systems and the health workforce.

Speaking Up for COPD: A global call for policy action

Transformation in COPD care is underway as Speak Up for COPD unites policymakers, healthcare professionals, patients, caregivers, NGOs, and pharmaceutical industry to help make COPD a public health priority.

Sales soar at Danish firm behind weight-loss drug semaglutide

Novo Nordisk says it struggling to keep up with demand after becoming Europeโ€™s most valuable companyBusiness live โ€“ latest updatesThe maker of blockbuster weight-loss drug semaglutide has reported a steep rise in sales and profits as health systems aro…

Several hospitalised in Austria after using suspected fake diabetes drug

Health regulator says serious side-effects possibly caused by insulin in counterfeit versions of Novo Nordiskโ€™s OzempicSeveral people have been admitted to hospital in Austria after using suspected fake versions of Novo Nordiskโ€™s diabetes drug Ozempic,…

Fake Ozempic: Several people hospitalized in Austria

Crime agency says individuals taking the counterfeit product to lose weight could have died without immediate treatment.

Why we need to improve heart health in Europe

Despite progress, there is now an increase in the cardiovascular disease burden across all major European countries.

Putting hearts first when it comes to aging healthily

Heart failure is the greatest health risk facing our aging population. Governments can help prevent premature death and โ€˜add life to our yearsโ€™ with immediate action and investment in accessible diagnostics.

Severe asthma โ€” breaking the cycle of inadequate care

The real cost of severe asthma: Why urgent action is needed to protect patients and reduce the strain on stretched health systems.

Wegovy maker Novo Nordisk becomes Europeโ€™s most valuable firm

Launch of weight-loss drug in UK helps Danish firm to market value of $428bnThe success of the weightloss drug Wegovy has helped its Danish manufacturer to overtake the French luxury group LVMH as Europeโ€™s most valuable company.After Novo Nordisk, whic…

Novo Nordisk prioritizes existing patients for weight-loss drug as demand soars

Social media influencers have fueled a surge in demand for Wegovy while a manufacturing hiccup has squeezed supplies of the medication.